Microbiology

Intestinal Microbiota Determines the Risk of MDRO Acquisition
Colonization and infection by multidrug-resistant organisms (MDRO) remains a public health problem. This is particularly important in intensive care units (ICUs) where the risk of MDRO acquisition/colonization results from the selective pressure associated with prolonged broad-spectrum antibiotic treatment. More...10 Feb 2022

Qiagen’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
QIAGEN N.V. (Venlo, Netherlands) has announced that its QuantiFERON tuberculosis (TB) testing solution has gained additional momentum with the approval of the fourth generation of this modern gold standard test in China and a new endorsement from the World Health Organization (WHO). More...08 Feb 2022

ABO Blood Group Related to Specific Immune Response to Anti-SARS-CoV-2
Markers of the protective humoral response, such as total anti-SARS-CoV-2 immunoglobulins and neutralizing antibodies, have been observed to decrease in convalescent individuals, even though a potential long-lasting humoral B-cell memory subset was detected. More...31 Jan 2022

MALDI-TOF Can Predict Antimicrobial Resistance in Clinical Samples
Antimicrobial-resistant bacteria and fungi pose a serious and increasing threat to the achievements of modern medicine. Infections with antimicrobial-resistant pathogens are associated with substantial morbidity, mortality and healthcare costs. More...27 Jan 2022

MCDA-LFB Assay Developed for Rapid Detection of Legionnaires’ Disease
Legionella pneumophila is an opportunistic waterborne pathogen of significant public health problems, which can cause serious human respiratory diseases (Legionnaires’ disease). Legionnaires’ disease is characterized by severe lung infection symptoms, including severe pneumonia with a high fatality rate. More...18 Jan 2022

Commercial RT-PCR Tests Compared to Culture for Bacterial Gastroenteritis
Nucleic acid-based testing (culture-independent diagnostic testing, CIDT) for bacterial gastroenteritis offers three major advantages over culture-based diagnosis: it has better analytical sensitivity, is less labor intensive through automation, and has faster turnaround times. More...11 Jan 2022

BD Introduces Smart Connected Robotics to Automate Microbial Identification
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its BD Kiestra IdentifA system, which is designed to automate the preparation of microbiology bacterial identification testing. More...10 Jan 2022
In Other News
Skin Infections Confirmed as a Cause of Acute Rheumatic Fever
Menstrual Blood Testing With Capture Sequencing Detects High-Risk Human Papillomavirus
Parkinson’s Disease Patients Have More Inflammatory Bacteria in Their Noses
Calprotectin Levels Vary When Measured in Different Matrices for COVID-19
Bacterial Communities Diverge in The Lower Airways of CF Children
Rapid, Highly Accurate Test Developed to Detect Viruses
Circulating ACE2 Activity Predicts Mortality and Severity in COVID-19 Patients
Beta-Lactamase Detection Reagent Rapidly Diagnoses Urinary ESBL-Producing Pathogens
Immunoprofiling HTLV-1 Blood Samples Show Altered Innate Cell Responsiveness
Cystic Pancreatic Lesion Bacteria Are Precursors to Pancreatic Cancer
Rapid Diagnostic Testing Analyzed in Suspected Meningitis Diagnosis
Same Day Test Identifies Secondary Infections in COVID-19 Patients
A Rapid and Sensitive Lateral Flow Test for Diagnosis of Schistosomiasis
Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections
P-O-C Test Detects IgG Antibody in Serodiagnosis of Human Trichinellosis
Breath Test Can Identify COVID-19 in Critically Ill Patients
Vircell Showcases Its Powerful Automation System and Immunoassay Testing Kits at MEDICA 2021
Stool Tests Rapidly Predict H. pylori Antibiotic Resistance
Neglected Protists Found in Immunocompetent and Immunodeficient Diarrheal Patients
Immune Chemokines Biomarkers Explored for Pediatric Tuberculosis Diagnosis
Scope Fluidics’ Microfluidic Antimicrobial Susceptibility System Obtains European CE IVD Marking Approval
YKL-40 Associated with Severity in Patients with Necrotizing Soft-Tissue Infection
Osteopontin Biomarker Evaluated for COVID-19 Severity and MIS-C
The LabMedica Microbiology channel provides the latest news in the fields of epidemiology, bacteriology, virology, and parasitology, all viewed from the unique perspective of Laboratory Medicine.